The selection of the technical parameters of plasmapheresis in the treatment of patients with MG varies widely due to the lack of sufficient data from controlled studies to standardize the plasmapheresis procedure. Eight myasthenia gravis (MG) patients (Osserman IIb and III) received either immunoad
Choline levels in plasma of myasthenia gravis patients and normal individuals
โ Scribed by Cathy Stein Ms; Walter Moore; Daniel Weinreich; Richard F. Mayer
- Publisher
- John Wiley and Sons
- Year
- 1978
- Tongue
- English
- Weight
- 219 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
โฆ Synopsis
Although the role of choline in blood is not well understood, several recent studies have attempted to link blood choline levels with diseases involving central cholinergic dysfunction [ l , 4, 61. It is well known that myasthenia gravis is a disease involving the neuromuscular junction in man, and it has been reported that a defect in acetylcholine synthesis might account for the clinical weakness [2]. In the present investigation, plasma choline levels of patients with myasthenia gravis were compared with those of normal individuals to determine whether this disease is associated with differences in free plasma choline concentrations.
๐ SIMILAR VOLUMES
To investigate the presence of antibodies in myasthenia gravis (MG) patients, we have developed a new reproducible and sensitive enzyme immunoassay (EIA-AChR), in which a โค subunit-specific monoclonal antibody (mAb 73) immobilizes fetal calf acetylcholine receptors (AChRs). We tested 92 MG patients
We analyzed the antibody (Ab) repertoires of IgM and IgG of patients with seropositive and patients with seronegative myasthenia gravis (MG) toward self antigens by means of a quantitative immunoblotting technique using normal human tissue extracts as sources of self antigens. Repertoires of reactiv
TT virus (TTV) infection is extremely widespread in the general population. A sensitive real-time PCR assay was developed that quantitated accurately the most prevalent TTV genotypes in Italy. When used to test 217 individuals for TTV viraemia, the overall prevalence was 94%. Viraemia levels varied